Lassa virus infections in humans can result in severe disease, including hemorrhagic fever. Here the authors describe an mRNA-based Lassa virus vaccine that shows protection without requirement for neutralizing antibody in a guinea pig model of infection.
- Adam J. Ronk
- Nicole M. Lloyd
- Alexander Bukreyev
